SCOPUS 정보 검색 플랫폼

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 1, 2002, Pages 4-7

Is there a place for non-selective NSAIDs in the treatment of arthritis?

(1) Crofford, Leslie J a,b

a UNIVERSITY OF MICHIGAN (United States)

b 5510e MSRB I ^* (United States)

Author keywords

Celecoxib; NSAIDs; Rofecoxib

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ARTHRITIS; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TOLERANCE; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; PRESCRIPTION; SYMPTOMATOLOGY;

EID: 0036156338 PISSN: 11698330 EISSN: None Source Type: Journal
DOI: 10.1016/S1169-8330(01)00240-X Document Type: Editorial

Times cited : (6)

References (18)

1
- 0027940487
- Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases
- (1994) J. Pharmacol. Exp. Ther. , vol.271 , pp. 1705-1712
- Patrignani, P.¹ Panara, M.R.² Greco, A.³

2
- 0034041077
- Basic biology and clinical application of specific COX-2 inhibitors
- (2000) Arthritis Rheum. , vol.43 , pp. 4-13
- Crofford, L.J.¹ Lipsky, P.E.² Brooks, P.³ Abramson, S.B.⁴ Simon, L.S.⁵ Van de Putte, L.B.A.⁶

3
- 0035145462
- Etoricoxib (MK-0663) : Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
- (2000) J. Pharmacol. Exp. Ther. , vol.296 , pp. 558-566
- Riendeau, D.¹ Percival, M.D.² Brideau, C.³ Charleson, S.⁴ Dube, D.⁵ Ethier, D.⁶

4
- 0034030366
- N[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl] propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration
- (2000) J. Med. Chem. , vol.43 , pp. 1661-1663
- Talley, J.J.¹ Bertenshaw, S.R.² Brown, D.L.³ Carter, J.S.⁴ Graneto, M.J.⁵ Kellogg, M.S.⁶

5
- 0034624748
- 4 [5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
- (2000) J. Med. Chem. , vol.43 , pp. 775-777
- Talley, J.J.¹ Brown, D.L.² Carter, J.S.³ Graneto, M.J.⁴ Koboldt, C.M.⁵ Masferrer, J.L.⁶

6
- 0035150435
- Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug
- (2001) Arthritis Rheum. , vol.44 , pp. 180-185
- Dougados, M.¹ Behier, J.M.² Jolchine, I.³ Calin, A.⁴ Van der Heijde, D.⁵ Olivieri, I.⁶

7
- 0034707105
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
- (2000) N. Engl. J. Med. , pp. 343
- Bombardier, C.¹ Laine, L.² Reicin, A.³ Shapiro, D.⁴ Burgos-Vargas, R.⁵ Davis, B.⁶

8
- 0034644396
- Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomized controlled trial
- (2000) JAMA , vol.284 , pp. 1247-1255
- Silverstein, F.E.¹ Faich, G.² Goldstein, J.L.³ Simon, L.S.⁴ Pincus, T.⁵ Whelton, A.⁶

9
- 0032468069
- A guideline for the prevention and treatment of NSAID-induced ulcers
- (1998) Am. J. Gastroenterol. , vol.93 , pp. 2037-2046
- Lanza, F.L.¹

10
- 0035967198
- Preventing recurrent upper gastrointestinal bleeding in patients with helicobacter pylori infection who are taking low-dose aspirin or naproxen
- (2001) N. Engl. J. Med. , vol.344 , pp. 967-973
- Chan, F.K.L.¹ Chung, S.C.S.² Suen, B.Y.³ Lee, Y.T.⁴ Leung, W.K.⁵ Leung, V.K.S.⁶

11
- 0035079023
- Renal effects of COX-2 selective inhibitors
- (2001) Am. J. Nephrol. , vol.21 , pp. 1-15
- Brater, D.C.¹ Harris, C.² Redfern, J.S.³ Gertz, B.J.⁴

12
- 0034189392
- Renal safety and tolerability of celecoxib, a novel cyclooxygenase inhibitor
- (2000) Am. J. Ther. , vol.7 , pp. 159-174
- Whelton, A.¹ Maurath, C.J.² Vergurg, K.M.³ Geis, G.S.⁴

13
- 0035286901
- Rofecoxib in older hypertensive osteoarthritis patients
- (2001) Am. J. Ther. , vol.8 , pp. 85-95
- Whelton, F.J.G.¹ Puma, J.A.² Normandin, D.³ Bello, A.E.⁴ Verburg, K.M.⁵

14
- 0004093997
- Comparative blood pressure effects of rofecoxib, celecoxib, and placebo in patients with osteoarthritis (OA): A randomized controlled trial [abstract]
- Presented at EULAR
- (2001)
- Geba, G.P.¹ Polis, A.B.² Dixon, M.E.³ Dobbins, T.W.⁴ Rush, J.E.⁵ Weir, M.R.⁶

15
- 0028354308
- Aspirin as an antiplatelet drug
- (1994) N. Engl. J. Med. , vol.330 , pp. 1287-1294
- Patrono, C.¹

16
- 0035910976
- Cyclooxygenase inhibition and thrombogenicity
- (2001) Am. J. Med. , vol.110 , Issue.SUPPL. , pp. 28-32
- Catella-Lawson, F.¹ Crofford, L.J.²

17
- 0035859802
- Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
- (2001) Circulation , vol.104
- Hennan, J.K.¹ Huang, J.² Barrett, T.C.³ Driscoll, E.M.⁴ Willens, D.E.⁵ Park, A.M.⁶

18
- 0033898782
- Thrombosis in patients with connective tissue diseases treated with specific COX-2 inhibitors : A report of four cases
- (2000) Arthritis Rheum. , vol.43 , pp. 1891-1896
- Crofford, L.J.¹ Oates, J.C.² McCune, W.J.³ Gupta, S.⁴ Kaplan, M.J.⁵ Catella-Lawson, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.